Purpose Cardiac autonomic dysfunction is one of the main pillars of cardiovascular
pathophysiology. The purpose of this review is to provide an overview of the current state of …

Heart failure (HF) is a major public health problem worldwide, especially coronary heart
disease (myocardial infarction)-induced HF with reduced ejection fraction (HFrEF), which …

Abstract Aims Neuropeptide Y (NPY) is the most abundant neuropeptide found in the heart
and is released alongside norepinephrine following prolonged sympathetic activation, a …

Despite all the important advances in its diagnosis and treatment, acute myocardial
infarction (AMI) is still one of the most prominent causes of morbidity and mortality …

Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) is an
important subtype of myocardial infarction. Although comprising less than 50% stenosis in …

Background: Coronary macrovascular disease is a concept that has been well-studied
within the literature and has long been the subject of debates surrounding coronary artery …

Cardiac disease is marked by sympathoexcitation and elevated levels of noradrenaline (NA)
and cotransmitter neuropeptide Y (NPY). Increased NPY levels are associated with a greater …

Background Acute myocardial infarction is associated with the release of the co-transmitter
neuropeptide-Y (NPY). NPY acts as a potent vasoconstrictor and is associated with …

This paper updates and builds on a previous White Paper in this journal that some of us
contributed to concerning the molecular and cellular basis of cardiac neurobiology of heart …

Abstract William Bayliss and Ernest Starling are not only famous as pioneers in
cardiovascular physiology, but also responsible for the discovery of the first hormone (from …